Learning Objectives:

  1. To become familiar with novel antihypertensive agents being developed.

 

  1. To become familiar with the place of renal denervation.

  

  1. To understand the deficit in HTN management is patient adherence rather than true resistance.
Session date: 
02/09/2024 - 12:00pm to 1:00pm CST
Location: 
Conference Room W-632/Zoom
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
George Bakris, MD